BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11444237)

  • 21. Frequency analysis and allele map in favor of the celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 2001; 27(2):549-56. PubMed ID: 11500066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-thalassemia trait might increase the severity of hemochromatosis in subjects with the C282Y mutation in the HFE gene.
    Arruda VR; Agostinho MF; Cançado R; Costa FF; Saad ST
    Am J Hematol; 2000 Apr; 63(4):230. PubMed ID: 10706769
    [No Abstract]   [Full Text] [Related]  

  • 23. HFE genotyping by amplification refractory mutation system-denaturing HPLC.
    Pissard S; Huynh LT; Martin J; Goossens M
    Clin Chem; 2002 May; 48(5):769-72. PubMed ID: 11978606
    [No Abstract]   [Full Text] [Related]  

  • 24. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations.
    Merryweather-Clarke AT; Simonsen H; Shearman JD; Pointon JJ; Nørgaard-Pedersen B; Robson KJ
    Hum Mutat; 1999; 13(2):154-9. PubMed ID: 10094552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HFE polymorphism and accurate diagnosis of C282Y hereditary hemochromatosis carriers.
    Elsea SH; Leykam V
    Blood; 2000 Apr; 95(7):2453-5. PubMed ID: 10787240
    [No Abstract]   [Full Text] [Related]  

  • 28. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary hemochromatosis associated with hypoceruloplasminemia with absence of mutations in the HFE gene]].
    Del Rey R; Froilán C; Comas C; Villanueva R; Olveira A
    Rev Esp Enferm Dig; 2000 Sep; 92(9):610-1. PubMed ID: 11138244
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemochromatosis gene C282Y homozygotes in an elderly male population.
    Willis G; Wimperis JZ; Smith KC; Fellows IW; Jennings BA
    Lancet; 1999 Jul; 354(9174):221-2. PubMed ID: 10421310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geography of HFE C282Y and H63D mutations.
    Merryweather-Clarke AT; Pointon JJ; Jouanolle AM; Rochette J; Robson KJ
    Genet Test; 2000; 4(2):183-98. PubMed ID: 10953959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The usefulness of the detection of Cys282Tyr and His63Asp mutations in the diagnosis of hereditary hemochromatosis].
    Moreno L; Vallcorba P; Boixeda D; Cabello P; Bermejo F; San Román C
    Rev Clin Esp; 1999 Oct; 199(10):632-6. PubMed ID: 10589245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
    Ryan E; Byrnes V; Coughlan B; Flanagan AM; Barrett S; O'Keane JC; Crowe J
    Gut; 2002 Jul; 51(1):108-12. PubMed ID: 12077102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemochromatosis in Ireland and HFE.
    Ryan E; O'keane C; Crowe J
    Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and management of haemochromatosis since the discovery of the HFE gene: a European experience.
    Br J Haematol; 2000 Jan; 108(1):31-9. PubMed ID: 10651721
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of C282Y and H63D in the HFE gene.
    Pointon JJ; Merryweather-Clarke AT; Carella M; Robson KJ
    Genet Test; 2000; 4(2):115-20. PubMed ID: 10953949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HFE, iron homeostasis and genetic hemochromatosis.
    Cazzola M
    Haematologica; 2000 Apr; 85(4):338-9. PubMed ID: 10756355
    [No Abstract]   [Full Text] [Related]  

  • 39. No association between factor V Leiden and C282Y mutation in the hereditary hemochromatosis gene.
    Le Maréchal C; Raguénés O; Ferec C
    Blood; 1999 Jun; 93(11):4024-5. PubMed ID: 10383194
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.